CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-20 | Piscitelli Dominic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-07-20 | Piscitelli Dominic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +108,750 | 108,750 | ||
| 2022-07-20 | Chacko Jacob President and CEO | Returned to the company · Stock Option (right to buy) | −437,500 | 0 | ||
| 2022-07-20 | Chacko Jacob President and CEO | Returned to the company · Stock Option (right to buy) | −280,000 | 0 | ||
| 2022-07-20 | Chacko Jacob President and CEO | Returned to the company · Stock Option (right to buy) | −300,000 | 0 | ||
| 2022-07-20 | Chacko Jacob President and CEO | Grant or award · Stock Option (right to buy) | +437,500 | 437,500 | ||
| 2022-07-20 | Chacko Jacob President and CEO | Grant or award · Stock Option (right to buy) | +280,000 | 280,000 | ||
| 2022-07-20 | Chacko Jacob President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2022-06-17 | You Angie Director | Grant or award · Stock Option (right to buy) | +45,158 | 45,158 | ||
| 2022-06-17 | Kunkel Lori Anne Director | Grant or award · Stock Option (right to buy) | +53,700 | 53,700 | ||
| 2022-06-17 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +53,700 | 53,700 | ||
| 2022-06-17 | Hoerter Steven L. Director | Grant or award · Stock Option (right to buy) | +50,283 | 50,283 | ||
| 2022-06-17 | Dier Mardi Director | Grant or award · Stock Option (right to buy) | +53,700 | 53,700 | ||
| 2022-05-13 | Chacko Jacob President and CEO | Purchase | +76,072 | $2.82 | $215K | 802,652 |
| 2022-05-12 | Chacko Jacob President and CEO | Purchase | +69,354 | $2.75 | $190K | 726,580 |
| 2022-05-11 | Chacko Jacob President and CEO | Purchase | +304,574 | $2.90 | $884K | 657,226 |
| 2022-03-31 | Piscitelli Dominic Chief Financial Officer | Purchase | +60,000 | $5.36 | $322K | 60,000 |
| 2022-03-25 | Chacko Jacob President and CEO | Purchase | +50,000 | $4.54 | $227K | 352,652 |
| 2022-03-24 | Chacko Jacob President and CEO | Purchase | +42,873 | $5.03 | $216K | 302,652 |
| 2022-03-23 | Chacko Jacob President and CEO | Purchase | +257,127 | $4.98 | $1.3M | 259,779 |
Page 10 of 12 · 228 trades